Latest News and Press Releases

As referred to in the Company Announcement 05/2024, Interim Financial Report Q2 2024 on August 26, NNIT was close to signing a large important strategic contract. NNIT has entered into a contract with...

NNIT has pursuant to article 19 of the Market Abuse Regulation received notification of transactions by person with managerial responsibilities in NNIT. Reference is made to the attached table...

Correction: The two metrics “Earnings per share” and “Diluted earnings per share” were incorrectly stated for 6M 2024 in the Q2 2024 interim financial report, company announcement 05/2024. The correct...

Q2 2024 key highlights Financial performance continued to improve during the second quarter with organic growth at 11.0% meaning NNIT is capturing market share, specifically in Denmark and Europe....

In August 2024, NNIT entered into an agreement with an existing large pharma customer in Region US to deliver strategic consulting services in the areas of Quality & Computer System Validation...

With reference to company announcement 9-2022, NNIT announces that it has engaged in a related party transaction involving the sale of a vendor loan note to Novo Holdings A/S issued in connection with...

Q1 2024 key highlights The first quarter results were as planned on an overall level. Organic revenue growth of 8.0% driven by Region Denmark and Region Europe partly offset by Region US and Region...

Today, NNIT A/S held its annual general meeting, at which the following were noted/approved: Financial year 2023 and 2024 The Chairman of the Board gave the Board of Directors’ report on the...

NNIT has pursuant to article 19 of the Market Abuse Regulation received notification of transactions by person with managerial responsibilities in NNIT. Reference is made to the attached table...

The Board of Directors gives notice of the annual general meeting for NNIT A/S, company registration (CVR) no. 21 09 31 06 (the “Company”), to be held Thursday, March 14, 2024, 2:00 pm (CET) at NNIT...